¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"opal codon"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® codon ÇÑ±Û ÄÚµ·, À¯ÀüÀÚºÎÈ£
¼³¸í   
  ´Ü¹éÁúÀÇ ¾Æ¹Ì³ë»ê ¹è¿­À» ±ÔÁ¤Çϴ Àü·É RNAÀÇ 3¿°±â ¹è¿­À» ¸»ÇÑ´Ù. ¾Æ¹Ì³ë»êÀÇ À¯Àü¾ÏÈ£¶ó°íµµ ÇÑ´Ù. Àü »ý¹°À» ÅëÇØ¼­ °øÅëÀ¸·Î DNAÀÇ ¿°±â¹è¿­·Î Ç¥½ÃÇÒ ¼öµµ ÀÖ´Ù. RNA¶Ç´Â DNA¸¦ ±¸¼ºÇϴ ³× Á¾·ùÀÇ ¿°±â(´ºÅ¬·¹¿ÀƼµå)¿¡¼­ ¸¸µé¾îÁö´Â ¿°±â¹è¿­ÀÇ ÃѼö´Â 64°³·Î, ±× ÁßÀÇ 61°³°¡ ¾Æ¹Ì³ë»êÀ» ÄÚµåÇϰí ÀÖ´Ù. ³ª¸ÓÁö ¼¼ °³(UAA, UAG, UGA)´Â ´Ü¹éÁú ÇÕ¼ºÀ» Á¤Áö½Ãų ºÎÈ£·Î Á¤ÁöÄÚµ·À̶ó ºÒ¸°´Ù. ´Ü¹éÁúÇÕ¼ºÀÇ °³½ÃÄÚµ·(AUG)Àº ¸ÞƼ¿À´ÑÀÇ ÄÚµ·°ú °øÅëÀÌÁö¸¸ °³½Ã tRNA¿¡ ÀÇÇØ¼­ ÀνĵȴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • codon
    ÄÚµ·, À¯ÀüÀÚºÎÈ£
  • initiation codon
    ½ÃÀÛÄÚµ·
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • codon
    ÄÚµ·, À¯ÀüÀÚºÎÈ£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • codon
    ÄÚµ·, À¯ÀüÀÚºÎÈ£
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • codon
    ÄÚµ·.
  • codon
    ÄÚµ·, À¯ÀüºÎÈ£.
  • codon
    ÄÚµ·, À¯ÀüÀÚºÎÈ£
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • opal codon
    ¿ÀÆÈ ÄÚµ·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • opal suppression
    ¿ÀÆÈ ¾ï¾Ð(åääâ)
  • chain termination codon
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) ÄÚµç
  • codegenerate codon
    "°øÃàÅð(Íìõê÷Ü)ÄÚµ·, (ÔÒ) synonym codon"
  • codon
    ÄÚµ·
  • codon dictionary
    ÄÚµ·»çÀü(Þöîð)
  • codon recognizing site
    ÄÚµ· ÀνÄ(ìããÛ) ÀÚ¸®
  • degenerate codon
    "ÃàÅð¼º(õê÷Üàõ) ÄÚµ·, (ÔÒ) synonym codon"
  • hypervariable codon
    ´Ùº¯ÀÌ(Òýܨì¶)ÄÚµ·
  • initiation codon
    °³½Ã(ËÒã·) ÄÚµ·
  • minority codon
    ¼Ò¼ö(á³â¦) ÄÚµ·
  • missense codon
    ¿ÀÀÎ(è¦ìã)ÄÚµ·
  • modulating codon
    Á¤Á¶(ïÚðà)ÄÚµ·
  • multiple codon recognition
    ´Ù(Òý)ÄÚµ· ÀÎÁö(ìãò±)
  • nonsense codon
    ³Í¼¾½º ÄÚµ·
  • ochre codon
    ¿À¿ìÄ¿ÄÚµ·
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
CAI Codon Adaptation Index
PTC premature termination codon
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • opal
    ´Ü¹é¼®
    ºñÁ¤Áú ¶Ç´Â ±×¿¡ °¡±î¿î ÇÔ¼ö ±Ô»ê¿° ±¤¹°. ¿ÀÆÈÀ̶ó°íµµ ÇÑ´Ù. È­ÇÐ ¼ººÐÀº SiO, nHOÀÌ´Ù. ¼öºÐÀº º¸Åë 5¡­l0 % ÇÔÀ¯Çϰí ÀÖÀ¸¸ç, ºÒ¼ø¹°·Î¼­ ¼®È¸, ¾Ë·ç¹Ì³ª, »êȭö, °íÅä µîÀÌ ¼¯ÀÎ °æ¿ìµµ ÀÖ´Ù. Çö¹Ì°æÇÏ¿¡¼­´Â ºñÁ¤ÁúÀ̳ª, X¼±¿¡ ÀÇÇØ È«¿¬¼®ÀÇ È¸Àý¼±À» ³ªÅ¸³½´Ù. À̰ÍÀº ¿ø·¡ ºñÁ¤Áú·Î µÈ ´Ü¹é¼®ÀÌ ¿À·£ ¼¼¿ùÀÌ Áö³ª È«¿¬¼®È­ÇÑ °ÍÀ̶ó°í ÇÑ´Ù. ±«»óÀ̸ç, ±× Ç¥¸éÀÌ Á¾Á¾ Æ÷µµ»ó, ½ÅÀå»ó, Á¾À¯¼®»óÀ» º¸ÀδÙ. ÀϹÝÀûÀ¸·Î Ä¡¹ÐÁúÀε¥, ¶§·Î ´Ù°øÁúÀ̰ųª Á¶Á¤ÁúÀÎ °Íµµ ÀÖ´Ù. ±»±â 5.5¡­6, ºñÁß l.9¡­2.3ÀÌ´Ù. ¹é»ö ¶Ç´Â ¹«»öÀÎ °æ¿ì°¡ ¸¹°í, Åõ¸í ¶Ç´Â ¹ÝÅõ¸íÇÏ´Ù. ÈçÈ÷ Ȳ»ö, Àû»ö, û»ö, ³ì»ö, °¥»öÀ» ¶ì¸ç, ¶§·Î´Â ¿©·¯ »öÀÌ ´Ùä·Ó°Ô ³ªÅ¸³ª°í, ¶Ç ¹æÇâ¿¡ µû¶ó »öÀÌ º¯Çϱ⵵ ÇÑ´Ù. ÀÌ·± Á¾·ù¸¦ ±Í´Ü¹é¼®
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
opal codon <molecular biology> The codon UGA, one of the three that causes termination of protein synthesis.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
opal <chemical> A mineral consisting, like quartz, of silica, but inferior to quartz in hardness and specific gravity.
The precious opal presents a peculiar play of colours of delicate tints, and is highly esteemed as a gem. One kind, with a varied play of colour in a reddish ground, is called the harlequin opal. The fire opal has colours like the red and yellow of flame. Common opal has a milky appearance. Menilite is a brown impure variety, occurring in concretions at Menilmontant, near Paris. Other varieties are cacholong, girasol, hyalite, and geyserite.
Origin: L. Opalus: cf. Gr, Skr. Upala a rock, stone, precious stone: cf. F. Opale.
Source: Websters Dictionary
(01 Mar 1998)
opal mutation <molecular biology> Mutation that changes any codon to the termination codon UGA.
(18 Nov 1997)
opal suppressor <molecular biology> A gene that codes for an altered tRNA so that its anticodon can recognise the opal codon and thus allows the continuation of protein synthesis. A suppressor of an opal mutation is a tRNA that is charged with the amino acid corresponding to the original codon or a neutral substitute. Some eukaryote cells normally synthesise opal suppressor tRNAs. The function of these is not clear and they usually do not prevent normal termination of protein synthesis at an opal codon.
(18 Nov 1997)
amber codon <molecular biology> One of the three terminator codons. Its sequence is UAG.
See: ochre codon, opal codon.
(18 Nov 1997)
ambiguous codon <molecular biology> A codon that codes for more than one amino acid.
(09 Oct 1997)
codon <molecular biology> The coding unit of DNA that specifies the function of the corresponding messenger RNA.
A triplet of bases recognised by anticodons on transfer RNA and hence specifying an amino acid to be incorporated into a protein sequence. The code is degenerate, i.e. Each amino acid has more than one codon. The stop codon determines the end of a polypeptide.
(18 Nov 1997)
codon, initiator Any codon that directs initiation of genetic translation (translation, genetic) by stimulating the binding of initiator trna. In prokaryotes, the codons aug or gug can act as initiators while in eukaryotes, aug is the only initiator codon.
(12 Dec 1998)
codon, nonsense A codon that is not assigned to an amino acid or to any stop signal. It was originally thought that nonsense codons were synonymous with terminator codons (codon, terminator) in that they signaled termination of a protein chain. Recent studies have found this not to be true.
(12 Dec 1998)
codon, terminator Any codon that signals the termination of genetic translation (translation, genetic) by triggering the hydrolysis of the aminoacyl bond connecting the completed polypeptide to the trna. Terminator codons (uaa, uag, and uga) do not specify amino acids.
(12 Dec 1998)
punctuation codon <molecular biology> The three codons, UAA known as ochre, UAG as amber and UGA as opal, that do not code for an amino acid but act as signals for the termination of protein synthesis.
They are not represented by any tRNA and termination is catalysed by protein release factors. There are two release factors in E. Coli, RF1 recognises UAA and UAG, RF2 recognises UAA and UGA. Eukaryotes have a single GTP requiring factor, eRF.
See: ochre suppressor, amber suppressor.
(13 Jan 1998)
start codon The codon 5' AUG in mRNA, at which polypeptide synthesis is started. It is recognised by formylmethionyl tRNA in bacteria and by methionyl tRNA in eukaryotes.
(18 Nov 1997)
stop codon <molecular biology> The three codons, UAA known as ochre, UAG as amber and UGA as opal, that do not code for an amino acid but act as signals for the termination of protein synthesis.
They are not represented by any tRNA and termination is catalysed by protein release factors. There are two release factors in E. Coli, RF1 recognises UAA and UAG, RF2 recognises UAA and UGA. Eukaryotes have a single GTP requiring factor, eRF.
See: ochre suppressor, amber suppressor.
(13 Jan 1998)
nonsense codon <molecular biology> The three codons, UAA (known as ochre), UAG (amber) and UGA (opal), that do not code for an amino acid but act as signals for the termination of protein synthesis.
Any mutation that causes a base change which produces a nonsense codon results in premature termination of protein synthesis and probably a nonfunctional or nonsense protein.
(13 Nov 1997)
initiating codon The trinucleotide AUG (or sometimes GUG) that codes for the first amino acid in protein sequences, formylmethionine; the latter is often removed post-transcriptionally.
Synonym: start codon.
(05 Mar 2000)
initiation codon The codon 5' AUG in mRNA, at which polypeptide synthesis is started. It is recognised by formylmethionyl tRNA in bacteria and by methionyl tRNA in eukaryotes.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • codon
    ÄÚµ·(À¯Àü Á¤º¸ÀÇ ÃÖ¼Ò ´ÜÀ§)
  • fire opal
    È­´Ü¹é¼®
  • opal
    ´Ü¹é¼®;¿ÀÆÈ
  • opal glass
    À¯¹é»ö À¯¸®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á